Bargersville, IN, United States of America

Christopher Carl Frye

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 392(Granted Patents)


Location History:

  • Bloomington, IN (US) (1999 - 2000)
  • Mooresville, IN (US) (2000)
  • Bargersville, IN (US) (2009 - 2022)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovative Contributions of Christopher Carl Frye

Introduction

Christopher Carl Frye, based in Bargersville, IN, is a notable inventor with a proven track record in the field of biotechnology. With a total of 12 patents to his name, his work primarily focuses on the development of antibodies for critical health applications, particularly in response to viral threats and cancer treatment.

Latest Patents

Frye has recently made significant advancements in the fight against viral infections, specifically with his patent on anti-coronavirus antibodies. This invention includes antibodies that bind to the SARS-CoV spike protein and the SARS-CoV-2 spike protein, offering methods of use for treating or preventing conditions associated with SARS or COVID-19. In addition, Frye has developed anti-CD137 antibodies that demonstrate agonist activity. These antibodies may be beneficial in treating both solid and hematological tumors, particularly when used in conjunction with chemotherapy and ionizing radiation.

Career Highlights

Throughout his career, Frye has made notable contributions while working for some prestigious organizations. He has held positions at Eli Lilly and Company and the United States of America, as represented by the Secretary of the Department of Health and Human Services. His work in these institutions has allowed him to develop groundbreaking techniques and approaches in biomedical research.

Collaborations

Frye's journey in innovation is further enhanced through collaboration with esteemed colleagues, including Radmila Micanovic and Lihua Huang. These partnerships have fostered a shared vision in advancing medical science and improving patient outcomes through innovative antibody therapies.

Conclusion

Christopher Carl Frye stands out as a prominent inventor dedicated to addressing critical health challenges through innovative antibody therapies. His extensive portfolio of patents speaks volumes about his commitment to improving treatment options for viral infections and cancer, ultimately contributing to the betterment of public health. His collaborations with industry leaders and fellow researchers further underscore the impact of his work in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…